Jason O’Byrne
Finanzdirektor/CFO bei CARIBOU BIOSCIENCES, INC.
Vermögen: 222 682 $ am 30.04.2024
Profil
Jason V.
O’Byrne is currently the Chief Financial & Accounting Officer at Caribou Biosciences, Inc. He also holds the position of Chief Financial Officer at the same company.
Previously, he worked as the Regional Controller at General Chemical Corp.
from 2002 to 2005.
From 2019 to 2021, he served as the Senior Vice President-Finance at Astellas Gene Therapies, Inc. Mr. O’Byrne completed his undergraduate degree at the University of British Columbia and holds an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.02.2024 | 59 224 ( 0,07% ) | 222 682 $ | 30.04.2024 |
Aktive Positionen von Jason O’Byrne
| Unternehmen | Position | Beginn |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Finanzdirektor/CFO | 09.02.2021 |
Ehemalige bekannte Positionen von Jason O’Byrne
| Unternehmen | Position | Ende |
|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.02.2021 |
General Chemical Corp.
 General Chemical Corp. Industrial SpecialtiesProcess Industries General Chemical Corp. supplies specialty chemicals. Its soldering fluxes are designed to reduce or virtually eliminate corrosion in soldered joints. The firm’s paint strippers are used for substrate such as aluminum, ferrous metals and other surfaces. The company was founded in 1980 and is headquartered in Brighton, MI. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Jason O’Byrne
| The Leonard N Stern School of Business | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
General Chemical Corp.
General Chemical Corp. Industrial SpecialtiesProcess Industries General Chemical Corp. supplies specialty chemicals. Its soldering fluxes are designed to reduce or virtually eliminate corrosion in soldered joints. The firm’s paint strippers are used for substrate such as aluminum, ferrous metals and other surfaces. The company was founded in 1980 and is headquartered in Brighton, MI. | Process Industries |
